Developing a vaccine for pandemic and emerging coronaviruses
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-10788051
This study is working on a new vaccine to help protect people from coronaviruses that could lead to serious outbreaks, so that one day, we can prevent severe illness from these viruses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10788051 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a vaccine to protect against coronaviruses that could cause pandemics or outbreaks. It involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating the vaccine's effectiveness and safety through animal studies. The goal is to prepare for both intentional and naturally occurring infectious disease outbreaks. Patients may benefit from the eventual availability of a vaccine that can prevent severe illness from these viruses.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for exposure to coronaviruses, such as healthcare workers and those in close contact with infected individuals.
Not a fit: Patients who are not at risk for exposure to coronaviruses or those who have already been vaccinated against similar viruses may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the risk of severe illness from pandemic coronaviruses.
How similar studies have performed: Previous research has shown success in developing vaccines for other infectious diseases, indicating a strong potential for this approach.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SAUNDERS, KEVIN — DUKE UNIVERSITY
- Study coordinator: SAUNDERS, KEVIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Disease Outbreaks